BioCentury
ARTICLE | Financial News

VaxInnate financial update

February 3, 2014 8:00 AM UTC

VaxInnate received about $2.1 million in non-dilutive funding under the Technology Business Tax Certificate Transfer Program in New Jersey. The program, which is sponsored by the New Jersey Economic D...